Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA.
Spaulding Rehabilitation Hospital, 300 1st Ave, Charlestown, MA 02129, USA.
Regen Med. 2020 Apr;15(4):1509-1518. doi: 10.2217/rme-2019-0105. Epub 2020 May 18.
To determine whether platelet-rich plasma (PRP) can successfully treat symptoms associated with proximal hamstring tendinopathy. Charts were retrospectively reviewed of patients with a diagnosis of chronic proximal hamstring tendinopathy who underwent an ultrasound-guided leukocyte-rich PRP injection to assess reported outcomes at baseline and final follow-up post-intervention. In 22 patients with a mean age of 48.7 years and mean symptom duration of 26.5 months, mean Numeric Pain Rating Scale and Victorian Institute of Sport Assessment Scale for Proximal Hamstring Tendinopathy subscores demonstrated statistically significant improvements (p < 0.05) at a mean of 7.91 months follow-up. Sixty-eight percent of patients demonstrated ≥50% reduction of pain. Pain and functional outcomes improved following injection of PRP.
为了确定富含血小板的血浆（PRP）是否能成功治疗与近端腘绳肌腱病相关的症状。对诊断为慢性近端腘绳肌腱病并接受超声引导下富含白细胞的 PRP 注射的患者进行了图表回顾性分析，以评估干预后基线和最终随访时的报告结果。在 22 名平均年龄为 48.7 岁、平均症状持续时间为 26.5 个月的患者中，平均数字疼痛评分和维多利亚州运动评估量表近端腘绳肌腱病亚评分在平均 7.91 个月的随访时均显示出统计学意义上的显著改善（p < 0.05）。68%的患者疼痛减轻≥50%。PRP 注射后疼痛和功能结果得到改善。
